Isabelle M Maisonneuve
Overview
Explore the profile of Isabelle M Maisonneuve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glick S, Maisonneuve I
Ann N Y Acad Sci
. 2017 Nov;
844(1):214-226.
PMID: 29090809
Ibogaine, an alkaloid extracted from Tabemanthe iboga, is being studied as a potential long-acting treatment for oploid and stimulant abuse as well as for alcoholism and smoking. Studies in this...
2.
Clemence A, Balkoski V, Schaefer B, Lee M, Bromley N, Maisonneuve I, et al.
Subst Abus
. 2015 Aug;
37(2):356-63.
PMID: 26308425
Background: The Substance Abuse and Mental Health Services Administration (SAMHSA) has recently begun to fund programs that train medical residents on how to utilize an evidence-based validated system known as...
3.
Clemence A, Balkoski V, Lee M, Poston J, Schaefer B, Maisonneuve I, et al.
Subst Abus
. 2015 Jul;
37(2):306-14.
PMID: 26176589
Background: Screening, brief intervention, and referral to treatment (SBIRT), an evidence-based validated system for providing early detection and brief treatment of substance use disorders, has been widely used in the...
4.
Glick S, Sell E, McCallum S, Maisonneuve I
Eur J Pharmacol
. 2011 Aug;
669(1-3):71-5.
PMID: 21871879
18-Methoxycoronaridine (18-MC), a putative anti-addictive agent, has been shown to decrease the self-administration of several drugs of abuse in rats. 18-MC is a potent antagonist at α3β4 nicotinic receptors. Consistent...
5.
Taraschenko O, Maisonneuve I, Glick S
Physiol Behav
. 2011 Feb;
103(3-4):308-14.
PMID: 21324333
Evidence suggests that the development of diet-induced obesity in males and females might be mediated by distinct mechanisms, warranting different treatment approaches. In previous studies from this laboratory, a high...
6.
Resistance of male Sprague-Dawley rats to sucrose-induced obesity: effects of 18-methoxycoronaridine
Taraschenko O, Maisonneuve I, Glick S
Physiol Behav
. 2010 Oct;
102(2):126-31.
PMID: 20951714
Evidence suggests that the development of obesity in males and females might be mediated by distinct mechanisms, warranting different treatment approaches. In previous studies from this laboratory, a high sucrose...
7.
Taraschenko O, Maisonneuve I, Glick S
Pharmacol Biochem Behav
. 2010 May;
96(3):247-50.
PMID: 20457177
18-Methoxycoronaridine (18-MC), a selective antagonist of alpha3beta4 nicotinic receptors, has been shown to reduce the self-administration of several drugs of abuse. Recently, this agent has also been shown to attenuate...
8.
Glick S, Sell E, Maisonneuve I
Eur J Pharmacol
. 2008 Oct;
599(1-3):91-5.
PMID: 18930043
The novel iboga alkaloid congener 18-methoxycoronaridine (18-MC) is a putative anti-addictive agent that has been shown, in rats, to decrease the self-administration of several drugs of abuse. Previous work has...
9.
Taraschenko O, Rubbinaccio H, Maisonneuve I, Glick S
Psychopharmacology (Berl)
. 2008 Aug;
201(3):339-50.
PMID: 18751969
Rationale: Excessive eating often leads to obesity. Although a variety of neurotransmitters and brain regions are involved in modulating food intake, a role of accumbal dopamine is thought to be...
10.
Taraschenko O, Rubbinaccio H, Shulan J, Glick S, Maisonneuve I
Neuropharmacology
. 2007 Jun;
53(1):18-26.
PMID: 17544456
Owing to multiple anatomical connections and functional interactions between the habenulo-interpeduncular and the mesolimbic pathways, it has been proposed that these systems could together mediate the reinforcing properties of addictive...